Skip to main content
Erschienen in: Cancer Causes & Control 12/2013

01.12.2013 | Original paper

Long-term trends in incidence, survival and mortality of primary penile cancer in England

verfasst von: Manit Arya, Ruoran Li, Kat Pegler, Vijay Sangar, John D. Kelly, Suks Minhas, Asif Muneer, Michel P. Coleman

Erschienen in: Cancer Causes & Control | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Few population-based studies exist of long-term trends in penile cancer. We report incidence and mortality trends in England over the 31 years 1979–2009 and survival trends over the 40 years 1971–2010.

Methods

We calculated annual incidence and mortality rates per 100,000 by age and calendar period. We estimated incidence and mortality rate ratios for cohorts born since 1890, and one- and five-year relative survival (%) by age and deprivation category.

Results

A total of 9,690 men were diagnosed with penile cancer during 1979–2009. Age-standardized incidence rates increased by 21 %, from 1.10 to 1.33 per 100,000. Mortality rates fell by 20 % after 1994, from 0.39 to 0.31 per 100,000. Survival analyses included 11,478 men diagnosed during 1971–2010. Five-year relative survival increased from 61.4 to 70.2 %. Five-year survival for men diagnosed 2006–2010 was 77 % for men aged under 60 years and 53 % for men aged 80–99 years. The 8 % difference in five-year survival (66–74 %) between men in the most affluent and most deprived groups was not statistically significant.

Conclusions

The 21 % increase in penile cancer incidence in England since the 1970s may be explained by changes in sexual practice, greater exposure to sexually transmitted oncogenic human papilloma viruses, and decreasing rates of childhood circumcision. Improvement in survival is likely due to advances in diagnostic, staging and surgical techniques. There is a need for public health education and potential preventative strategies to address the increasing incidence.
Literatur
3.
Zurück zum Zitat World Health Organisation (1994) International statistical classification of diseases and related health problems. Tenth revision. WHO, Geneva World Health Organisation (1994) International statistical classification of diseases and related health problems. Tenth revision. WHO, Geneva
4.
Zurück zum Zitat Office for National Statistics (2011) Population Estimates for UK, England and Wales, Scotland and Northern Ireland–Population Estimates Timeseries 1971 to Current Year Office for National Statistics (2011) Population Estimates for UK, England and Wales, Scotland and Northern Ireland–Population Estimates Timeseries 1971 to Current Year
5.
Zurück zum Zitat Waterhouse JAH, Muir CS, Correa P, Powell J (1976) Cancer incidence in five continents, vol 3. IARC Scientific Publications, Lyon Waterhouse JAH, Muir CS, Correa P, Powell J (1976) Cancer incidence in five continents, vol 3. IARC Scientific Publications, Lyon
6.
Zurück zum Zitat Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG (eds) (1991) Cancer registration: principles and methods (IARC Scientific Publications No. 95). International Agency for Research on Cancer, Lyon Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG (eds) (1991) Cancer registration: principles and methods (IARC Scientific Publications No. 95). International Agency for Research on Cancer, Lyon
7.
Zurück zum Zitat Rachet B, Woods LM, Mitry E, Riga M, Cooper C, Quinn MJ, Steward JA, Brenner H, Estève J, Sullivan R, Coleman MP (2008) Cancer survival in England and Wales at the end of the 20th century. Br J Cancer 99(Suppl. 1):2–10CrossRef Rachet B, Woods LM, Mitry E, Riga M, Cooper C, Quinn MJ, Steward JA, Brenner H, Estève J, Sullivan R, Coleman MP (2008) Cancer survival in England and Wales at the end of the 20th century. Br J Cancer 99(Suppl. 1):2–10CrossRef
8.
Zurück zum Zitat Brenner H, Rachet B (2004) Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 40:2494–2501PubMedCrossRef Brenner H, Rachet B (2004) Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 40:2494–2501PubMedCrossRef
9.
Zurück zum Zitat Corazziari I, Quinn MJ, Capocaccia R (2004) Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40:2307–2316PubMedCrossRef Corazziari I, Quinn MJ, Capocaccia R (2004) Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40:2307–2316PubMedCrossRef
10.
Zurück zum Zitat Department of the Environment Transport and the Regions (2000) Measuring multiple deprivation at the small area level: the indices of deprivation 2000. DETR, London Department of the Environment Transport and the Regions (2000) Measuring multiple deprivation at the small area level: the indices of deprivation 2000. DETR, London
12.
Zurück zum Zitat Graafland NM, Verhoeven RH, Coebergh JW, Horenblas S (2011) Incidence trends and survival of penile squamous cell carcinoma in the Netherlands. Int J Cancer 128:426–432PubMedCrossRef Graafland NM, Verhoeven RH, Coebergh JW, Horenblas S (2011) Incidence trends and survival of penile squamous cell carcinoma in the Netherlands. Int J Cancer 128:426–432PubMedCrossRef
13.
Zurück zum Zitat Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Giuliano AR (2007) Incidence trends in primary malignant penile cancer. Urol Oncol 25:361–367PubMedCrossRef Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Giuliano AR (2007) Incidence trends in primary malignant penile cancer. Urol Oncol 25:361–367PubMedCrossRef
14.
Zurück zum Zitat Goodman MT, Hernandez BY, Shvetsov YB (2007) Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995–2003. Cancer Epidemiol Biomarkers Prev 16:1833–1839PubMedCrossRef Goodman MT, Hernandez BY, Shvetsov YB (2007) Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995–2003. Cancer Epidemiol Biomarkers Prev 16:1833–1839PubMedCrossRef
15.
Zurück zum Zitat Pukkala E, Weiderpass E (2002 Dec) Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971–95. Int J Cancer 20(102):643–648CrossRef Pukkala E, Weiderpass E (2002 Dec) Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971–95. Int J Cancer 20(102):643–648CrossRef
16.
Zurück zum Zitat Frisch M, Friis S, Kjaer SK, Melbye M (1995) Falling incidence of penis cancer in an uncircumcised population (Denmark 1943–90). BMJ 311:1471PubMedCrossRef Frisch M, Friis S, Kjaer SK, Melbye M (1995) Falling incidence of penis cancer in an uncircumcised population (Denmark 1943–90). BMJ 311:1471PubMedCrossRef
17.
Zurück zum Zitat Dillner J, von Krogh G, Horenblas S, Meijer CJ (2000) Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl 205:189–193PubMedCrossRef Dillner J, von Krogh G, Horenblas S, Meijer CJ (2000) Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl 205:189–193PubMedCrossRef
18.
Zurück zum Zitat Health Protection Agency. Health Protection Report. 2011. Apr 28. Vol 5. No.17 Health Protection Agency. Health Protection Report. 2011. Apr 28. Vol 5. No.17
19.
Zurück zum Zitat Arya M, Kalsi J, Kelly J, Muneer A (2013) Malignant and premalignant lesions of the penis. BMJ 346:f1149PubMedCrossRef Arya M, Kalsi J, Kelly J, Muneer A (2013) Malignant and premalignant lesions of the penis. BMJ 346:f1149PubMedCrossRef
20.
Zurück zum Zitat Robinson D, Coupland V, Moller H (2009) An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer 100:527–531PubMedCrossRef Robinson D, Coupland V, Moller H (2009) An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer 100:527–531PubMedCrossRef
21.
Zurück zum Zitat Poblet E, Alfaro L, Fernander-Segoviano P, Jimenez-Reyes J, Salido EC (1999) Human papillomavirus-associated penile squamous cell carcinoma in HIV-positive patients. Am J Surg Pathol 23:1119–1123PubMedCrossRef Poblet E, Alfaro L, Fernander-Segoviano P, Jimenez-Reyes J, Salido EC (1999) Human papillomavirus-associated penile squamous cell carcinoma in HIV-positive patients. Am J Surg Pathol 23:1119–1123PubMedCrossRef
22.
Zurück zum Zitat Castellsague X, Bosch FX, Munoz N et al (2002) Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 346:1105–1112PubMedCrossRef Castellsague X, Bosch FX, Munoz N et al (2002) Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 346:1105–1112PubMedCrossRef
23.
Zurück zum Zitat Rickwood AM, Kenny SE, Donnell SC (2000) Towards evidence based circumcision of English boys: survey of trends in practice. BMJ 321:792–793PubMedCrossRef Rickwood AM, Kenny SE, Donnell SC (2000) Towards evidence based circumcision of English boys: survey of trends in practice. BMJ 321:792–793PubMedCrossRef
24.
Zurück zum Zitat Swerdlow AJ, Dos Santos Silva I, Doll R (2001) Cancer incidence and mortality in England and Wales: trends and risk factors. Oxford University Press, OxfordCrossRef Swerdlow AJ, Dos Santos Silva I, Doll R (2001) Cancer incidence and mortality in England and Wales: trends and risk factors. Oxford University Press, OxfordCrossRef
25.
Zurück zum Zitat Office for National Statistics (2012). General Lifestyle Survey Overview Office for National Statistics (2012). General Lifestyle Survey Overview
26.
Zurück zum Zitat Castellsague X, Munoz N (2003) Chapter 3: cofactors in human papillomavirus carcinogenesis–role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20–28PubMedCrossRef Castellsague X, Munoz N (2003) Chapter 3: cofactors in human papillomavirus carcinogenesis–role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20–28PubMedCrossRef
27.
Zurück zum Zitat Kroon BK, Horenblas S, Meinhardt W et al (2005) Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol 47:601–606PubMedCrossRef Kroon BK, Horenblas S, Meinhardt W et al (2005) Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol 47:601–606PubMedCrossRef
28.
Zurück zum Zitat Hadway P, Smith Y, Corbishley C, Heenan S, Watkin NA (2007) Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma. BJU Int 100:561–565PubMedCrossRef Hadway P, Smith Y, Corbishley C, Heenan S, Watkin NA (2007) Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma. BJU Int 100:561–565PubMedCrossRef
29.
Zurück zum Zitat Verhoeven RH, Janssen-Heijnen ML, Saum KU et al (2013) Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. Eur J Cancer 49:1414–1421PubMedCrossRef Verhoeven RH, Janssen-Heijnen ML, Saum KU et al (2013) Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. Eur J Cancer 49:1414–1421PubMedCrossRef
30.
Zurück zum Zitat Pietrzak P, Corbishley C, Watkin N (2004) Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int 94:1253–1257PubMedCrossRef Pietrzak P, Corbishley C, Watkin N (2004) Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU Int 94:1253–1257PubMedCrossRef
31.
Zurück zum Zitat Hernandez BY, Barnholtz-Sloan J, German RR et al (2008) Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. Cancer 113(10 Suppl):2883–2891PubMedCrossRef Hernandez BY, Barnholtz-Sloan J, German RR et al (2008) Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. Cancer 113(10 Suppl):2883–2891PubMedCrossRef
Metadaten
Titel
Long-term trends in incidence, survival and mortality of primary penile cancer in England
verfasst von
Manit Arya
Ruoran Li
Kat Pegler
Vijay Sangar
John D. Kelly
Suks Minhas
Asif Muneer
Michel P. Coleman
Publikationsdatum
01.12.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 12/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0293-y

Weitere Artikel der Ausgabe 12/2013

Cancer Causes & Control 12/2013 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.